CALC
Price
$1.50
Change
-$0.02 (-1.32%)
Updated
Apr 25 closing price
Capitalization
20.22M
OBIO
Price
$2.78
Change
+$0.20 (+7.75%)
Updated
Apr 25 closing price
Capitalization
106.51M
Ad is loading...

CALC vs OBIO

Header iconCALC vs OBIO Comparison
Open Charts CALC vs OBIOBanner chart's image
CalciMedica
Price$1.50
Change-$0.02 (-1.32%)
Volume$20.39K
Capitalization20.22M
Orchestra BioMed Holdings
Price$2.78
Change+$0.20 (+7.75%)
Volume$292.29K
Capitalization106.51M
CALC vs OBIO Comparison Chart
Loading...
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CALC vs. OBIO commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CALC is a Buy and OBIO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (CALC: $1.50 vs. OBIO: $2.78)
Brand notoriety: CALC and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CALC: 47% vs. OBIO: 77%
Market capitalization -- CALC: $20.22M vs. OBIO: $106.51M
CALC [@Biotechnology] is valued at $20.22M. OBIO’s [@Biotechnology] market capitalization is $106.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CALC’s FA Score shows that 1 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • CALC’s FA Score: 1 green, 4 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, CALC is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CALC’s TA Score shows that 6 TA indicator(s) are bullish while OBIO’s TA Score has 6 bullish TA indicator(s).

  • CALC’s TA Score: 6 bullish, 2 bearish.
  • OBIO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, CALC is a better buy in the short-term than OBIO.

Price Growth

CALC (@Biotechnology) experienced а -3.23% price change this week, while OBIO (@Biotechnology) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

CALC is expected to report earnings on Mar 27, 2025.

OBIO is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OBIO($107M) has a higher market cap than CALC($20.2M). OBIO YTD gains are higher at: -30.500 vs. CALC (-57.627). CALC has higher annual earnings (EBITDA): -18.46M vs. OBIO (-59.81M). OBIO has more cash in the bank: 66.9M vs. CALC (14.6M). CALC has less debt than OBIO: CALC (203K) vs OBIO (1.84M). OBIO has higher revenues than CALC: OBIO (2.65M) vs CALC (0).
CALCOBIOCALC / OBIO
Capitalization20.2M107M19%
EBITDA-18.46M-59.81M31%
Gain YTD-57.627-30.500189%
P/E Ratio0.30N/A-
Revenue02.65M-
Total Cash14.6M66.9M22%
Total Debt203K1.84M11%
TECHNICAL ANALYSIS
Technical Analysis
CALCOBIO
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
58%
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
55%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
38%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
59%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
Bullish Trend 12 days ago
59%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
63%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
55%
View a ticker or compare two or three
Ad is loading...
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALSMY2.350.03
+1.29%
Alstom
VWDRY4.390.04
+0.92%
Vestas Wind Systems A/S
MPNGY33.180.12
+0.36%
MEITUAN
TNEYF2.72N/A
N/A
Tamarack Valley Energy, Ltd.
CWBHF0.08N/A
-5.17%
Charlotte's Web Holdings Inc.

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with ETNB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
+7.75%
ETNB - OBIO
37%
Loosely correlated
+0.58%
GBIO - OBIO
36%
Loosely correlated
+1.55%
INSM - OBIO
36%
Loosely correlated
+1.06%
ERAS - OBIO
34%
Loosely correlated
-0.71%
KALV - OBIO
33%
Loosely correlated
+0.85%
More